Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study.
Eleni KampylafkaIsabelle d'OliveiraChristina LinzVeronika LerchenFabian StemmlerDavid SimonMatthias EnglbrechtMichael SticherlingJürgen RechArnd KleyerGeorg SchettAlexander PfeilPublished in: Arthritis research & therapy (2018)
ClinicalTrials.gov Identifier: NCT02483234 , June 26, 2015; retrospectively registered.